DrugPatentWatch Database Preview
Drugs in Development Information for Gimeracil
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Gimeracil?
Gimeracil is an investigational drug.
There have been 61 clinical trials for Gimeracil.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2013.
The most common disease conditions in clinical trials are Stomach Neoplasms, Pancreatic Neoplasms, and Carcinoma. The leading clinical trial sponsors are Fudan University, Taiho Oncology, Inc., and Yonsei University.
There are one hundred and sixteen US patents protecting this investigational drug and nine hundred and forty-seven international patents.
Summary for Gimeracil
| US Patents | 116 |
| International Patents | 947 |
| US Patent Applications | 196 |
| WIPO Patent Applications | 101 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2013-06-01) |
| Vendors | 87 |
Recent Clinical Trials for Gimeracil
| Title | Sponsor | Phase |
|---|---|---|
| Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma | RenJi Hospital | Phase 2 |
| A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer | Shanghai Henlius Biotech | Phase 3 |
| SOX-based CRT for Esophageal Cancer. | Zhejiang Provincial People’s Hospital | Phase 1/Phase 2 |
Clinical Trial Summary for Gimeracil
Top disease conditions for Gimeracil
Top clinical trial sponsors for Gimeracil
US Patents for Gimeracil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Gimeracil | Start Trial | Metal-salen complex compound, local anesthetic and antineoplastic drug | IHI Corporation (Tokyo, JP) Ishikawa; Yoshihiro (Tokyo, JP) | Start Trial |
| Gimeracil | Start Trial | Multimodal silica-based nanoparticles | Start Trial | |
| Gimeracil | Start Trial | Device and method for drug evaluation and local treatment | Kibur Medical, Inc. (Boston, MA) | Start Trial |
| Gimeracil | Start Trial | Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs in cancer cells | STC.UNM (Albuquerque, NM) | Start Trial |
| Gimeracil | Start Trial | Pharmaceutical compositions comprising POH derivatives | NeOnc Technologies, inc. (Los Angeles, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Gimeracil
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Gimeracil | China | 103781760 | 2031-06-13 | Start Trial |
| Gimeracil | European Patent Office | 2738158 | 2031-06-13 | Start Trial |
| Gimeracil | Japan | 2013001646 | 2031-06-13 | Start Trial |
| Gimeracil | Japan | 5873656 | 2031-06-13 | Start Trial |
| Gimeracil | Russian Federation | 2013156414 | 2031-06-13 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
